Pharmaco - Press Releases

Date	Title	Company
01-Jul-2020	Last of 12,400 Participants Completes Final Visit in BiondVax's M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial	BiondVax Pharmaceuticals Ltd.
01-Jul-2020	Xlife Sciences AG: Xlife Sciences shares traded on XETRA	Xlife Sciences AG
30-Jun-2020	Annual financial statements 2019: 9% sales growth and strongly improved EBITDA; significant milestones and growing interest in pioneering key technologies antibacterial silver coating and resorbable magnesium implants	aap Implantate AG
30-Jun-2020	ACMA Launches Medication Safety Service to Mitigate New Product Risks	Accreditation Council for Medical Affairs
30-Jun-2020	Immunosuppressive Drug Used to Treat Rheumatic Diseases May Help Select COVID-19 Patients Avoid Mechanical Ventilation	Hospital for Special Surgery
30-Jun-2020	Vivera Pharmaceuticals files multi-million dollar lawsuit against USA Today, parent company Gannett, reporters and executives	Vivera Pharmaceuticals, Inc.
30-Jun-2020	Registration opens for SMi’s 4th Annual Ophthalmic Drugs Conference	SMi Group Ltd
30-Jun-2020	Developing custom syringes for highly viscous formulations to be discussed at the Pre-filled Syringes San Francisco Conference	SMi Group Ltd
30-Jun-2020	curasan AG: curasan AG postpones annual financial report 2019 to 31 July 2020	curasan AG
30-Jun-2020	Number of Shares and Votes in Oncopeptides	Oncopeptides AB
30-Jun-2020	Transdermal Drug Delivery System Market Leading Players: Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, UCB, Teikoku Seiyaku and Among others	Regal Intelligence
30-Jun-2020	Original-Research: MPH Health Care (von First Berlin Equity Research GmbH)	MPH Health Care
30-Jun-2020	US FDA Grants Orphan Drug Designation (ODD) for Prestige BioPharma’s PBP1510 Anti-PAUF Monoclonal Antibody for the Treatment of Pancreatic Cancer	B3C newswire
30-Jun-2020	Oncopeptides Submits a New Drug Application to the FDA for Accelerated Approval of Melflufen in Triple-class Refractory Multiple Myeloma Patients	Oncopeptides AB
30-Jun-2020	MagForce AG Publishes Financial Results for the Year 2019 and Operative Highlights (news with additional features)	MagForce AG
30-Jun-2020	Alterity Therapeutics meeting with US FDA provides development pathway for ATH434	Alterity Therapeutics
29-Jun-2020	Blueprint Medicines Announces Publication in The Lancet Oncology Showing Durable Clinical Benefits of AYVAKIT(TM) (avapritinib) in NAVIGATOR Trial Patients with PDGFRA D842V Mutant GIST	Blueprint Medicines Corporation
29-Jun-2020	aap Implantate AG: Refusal of audit opinions for annual financial report 2019 (HGB) and consolidated annual financial report 2019 (IFRS); implementation of various financing and cost-saving options to secure financing	aap Implantate AG
29-Jun-2020	Sabar Health and Vaica Medical Announce Collaboration to Offer Digitally Connected Patient Support Services for Home Hospitalizations	Vaica Medical
29-Jun-2020	PTC Therapeutics Announces CHMP Recommendation of TranslarnaTM (ataluren) Label Update for Non-Ambulatory Patients with Duchenne Muscular Dystrophy	PTC Therapeutics, Inc